Kyoto, Japan

Toru Mori

This inventor holds 1 USPTO granted patent. Top assignee: Ishihara Sangyo Kaisha, Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toru Mori. Retrieved from https://idiyas.com/inventor/toru-mori-8ef6m03x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Toru Mori

Introduction

Toru Mori is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of autoimmune disorders. His work has led to the development of innovative solutions that address critical health issues.

Latest Patents

Toru Mori holds a patent for a peptide or its salt for autoimmune hyperthyroidism. This peptide has a specific formula that aims to provide therapeutic benefits for individuals suffering from this condition. His patent represents a significant advancement in the treatment of autoimmune diseases.

Career Highlights

Mori is associated with Ishihara Sangyo Kaisha, Ltd., a company known for its commitment to research and development in the pharmaceutical sector. His role at the company has allowed him to focus on innovative research that has the potential to improve patient outcomes.

Collaborations

Throughout his career, Toru Mori has collaborated with esteemed colleagues such as Hideo Sugawa and Yoshimichi Ueda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Toru Mori's contributions to the field of biotechnology, particularly through his patent for a peptide for autoimmune hyperthyroidism, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…